Joseph Wolk
Direttore Finanziario/CFO presso JOHNSON & JOHNSON
Patrimonio netto: 11 M $ in data 30/04/2024
Profilo
Joseph J. Wolk ricopre la posizione di Chief Financial Officer & Executive Vice President in Johnson & Johnson. Il signor Wolk è anche membro del Cnbc Global Cfo Council. Il signor Wolk si è laureato alla St. Joseph's University e si è laureato alla Temple University Beasley School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
JOHNSON & JOHNSON
0.00% | 15/02/2024 | 70 938 ( 0.00% ) | 10 M $ | 30/04/2024 |
KENVUE, INC.
0.00% | 23/05/2024 | 8 307 ( 0.00% ) | 157 999 $ | 30/04/2024 |
Posizioni attive di Joseph Wolk
| Società | Posizione | Inizio |
|---|---|---|
| JOHNSON & JOHNSON | Direttore Finanziario/CFO | 01/07/2018 |
| KENVUE INC. | Direttore/Membro del Consiglio | 08/05/2023 |
Cnbc Global Cfo Council
 Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Corporate Officer/Principal | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Wall Street Journal Cfo Network
 Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Corporate Officer/Principal | - |
| St. Joseph's University | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Joseph Wolk
| Società | Posizione | Fine |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Direttore Finanziario/CFO | 01/01/2016 |
Formazione di Joseph Wolk
| St. Joseph's University | Undergraduate Degree |
| Temple University Beasley School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| KENVUE INC. | Consumer Non-Durables |
| Aziende private | 3 |
|---|---|
Cnbc Global Cfo Council
Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Commercial Services |
Wall Street Journal Cfo Network
Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Commercial Services |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Joseph Wolk
